Clinical trial

CXCL10 As a Biomarker Of ILD in Patients WithRA

NCT04356066

Study summary

ClinicalTrials.gov

CXCL10 As a Biomarker Of ILD in Patients WithRA

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention serum cxcl10 by ELISA Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-12-19

PhaseNA

Conditions

Interstitial Lung Disease in Patients With Rheumatoid Arthritisunresolved

Interventions

serum cxcl10 by ELISADIAGNOSTIC_TEST

Sponsors & collaborators

Assiut Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04356066 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.